Financial News
Latest News about MRK
Recent news which mentions MRK
From Benzinga
From Motley Fool
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
Here's Why Novocure Dipped 19% This Week
July 30, 2021
From Motley Fool
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
Merck Stock Falls As Q2 Earnings Lag Wall Street Estimates, Trimmed FY21 Guidance Below Consensus
July 29, 2021
Tickers
MRK
From Benzinga
A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of GDP, Jobless Claims Data
July 29, 2021
From Benzinga
Here’s why the 10-year yield is so low, and the summer event that could change it, from Bank of America
July 29, 2021
From MarketWatch
7 Stocks To Watch For July 29, 2021
July 29, 2021
From Benzinga
Earnings Scheduled For July 29, 2021
July 29, 2021
From Benzinga
The IPO Recap – Party Is Everything But Over
July 28, 2021
From Benzinga
Earning Reports Fom Household Names This Week. PART 1
July 27, 2021
From Benzinga
From Benzinga
Merck's Keytruda Combo Trial Meets Overall Survival Endpoint In PD-L1 Expressing Breast Cancer Patients
July 27, 2021
Tickers
MRK
From Benzinga
From Benzinga
From Motley Fool
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
From Benzinga
Adagene To Test Its Anti-CTLA-4 Monoclonal Antibodies In Combination With Keytruda In Solid Tumors
July 22, 2021
From Benzinga
From Benzinga
3 Top Tech Stocks to Buy During a Recession
July 22, 2021
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
